Daniel Starobin
Rabin Medical Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Daniel Starobin.
The Annals of Thoracic Surgery | 2003
David Shitrit; Gabriel Izbicki; Daniel Starobin; D Aravot; Mordechai R. Kramer
Chylothorax has rarely been reported after heart and lung transplantation. We describe a case of a bilateral chylothorax that occurred in a 53-year-old man 4 months after heart-lung transplantation and review the three additional reports in the literature of chylothorax after heart transplantation. Chyle drainage may cause compromise of the transplant patient. The good nutritional status of our recipient, however, allowed conservative therapy with chest tube drainage and enteral low-fat diet, without the need for surgical intervention. We concluded that chylothorax can presents late after lung transplantation and that conservative treatment should be considered in patients with good nutritional status.
Transplantation Proceedings | 2003
Daniel Starobin; Gershon Fink; David Shitrit; Gabriel Izbicki; D Bendayan; Ilana Bakal; Mordechai R. Kramer
ULMONARY INFECTIOUS complications are common in patients after solid organ transplantation (SOT) or bone marrow transplantation (BMT) and are responsible for significant morbidity and mortality. Early diagnosis of infectious complications is extremely important for the outcome of transplant recipients 1‐3 The purpose of this study was to examine the role of fiberoptic bronchoscopy (FOB) in transplant recipients with suspected pulmonary infections. METHODS The study was conducted at the Institute of Pulmonary Medicine. Rabin Medical Center, Beilinson Campus (a tertiary-care university hospital). We retrospectively examined data of patients posttransplantation who required FOB from May 5, 1999 until May 2002. Indications for FOB were suspected pulmonary infection by either abnormal chest X-ray or respiratory symptoms. Lung transplant recipients with surveillance bronchoscopies were excluded from the study. Patients underwent bronchoalveolar lavage (BAL); specimens were analyzed as bacteriology, virology, fungal, and mycobacterial cultures. In 65% of cases, transbronchial biopsies (TBBs) were done; specimens were sent to pathological examination as well as silver and cytomegalovirus (CMV)-specific stains.
Respiratory Care | 2011
Daniel Starobin; Vladimir Guller; Alexander Gurevich; Gershon Fink; Monica Huszar; Sari Tal
Mycobacterium kansasii disease was diagnosed in an 85-year-old woman admitted to the hospital for cough and gradually worsening breathlessness. Transbronchial biopsy indicated either non-necrotizing granulomata or bronchiolitis obliterans organizing pneumonia (BOOP). She was cured with combined therapy of specific anti-mycobacterial medications and systemic steroids. To our knowledge, this is the first report of M. kansasii non-tuberculous mycobacterium disease with a BOOP-like pattern on lung biopsy.
Israel Medical Association Journal | 2006
Daniel Starobin; Mordechai R. Kramer; Alexander Yarmolovsky; Daniel Bendayan; Izhak Rosenberg; Jacqueline Sulkes; Gershon Fink
Journal of Vascular Surgery | 2002
David Shitrit; Ariela Bar-Gil Shitrit; Daniel Starobin; Gabriel Izbicki; Alexander Belenky; Natan Kaufman; Mordechai R. Kramer
Transplantation Proceedings | 2003
David Shitrit; Daniel Starobin; D Aravot; Gershon Fink; Gabriel Izbicki; Mordechai R. Kramer
Israel Medical Association Journal | 2007
Daniel Starobin; Marina Bargutin; Itzhak Rosenberg; Alexander Yarmolovsky; Tali Levi; Gershon Fink
Israel Medical Association Journal | 2005
Jonathan D. Cohen; Daniel Starobin; Gregory Papirov; Maury Shapiro; Elad Grozovsky; Mordechai R. Kramer; Pierre Singer
Israel Medical Association Journal | 2008
Daniel Starobin; Ludmila Bolotinsky; Jack Or; Gershon Fink; Zev Shtoeger
Israel Medical Association Journal | 2008
Daniel Starobin; Miriam Katz; Monica Huszar; Zev Shtoeger